Cholangiocarcinoma diagnostic study of choice

Jump to navigation Jump to search

Cholangiocarcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholangiocarcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangiocarcinoma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangiocarcinoma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangiocarcinoma diagnostic study of choice

CDC on Cholangiocarcinoma diagnostic study of choice

Cholangiocarcinoma diagnostic study of choice in the news

Blogs on Cholangiocarcinoma diagnostic study of choice

Directions to Hospitals Treating Cholangiocarcinoma

Risk calculators and risk factors for Cholangiocarcinoma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

The staging of cholangiocarcinoma varies depending on whether the tumor is primarily intrahepatic (ICC), hilar/perihilar, or extrahepatic.

Diagnostic Study of Choice

The staging of cholangiocarcinoma varies depending on whether the tumor is primarily intrahepatic (ICC), hilar/perihilar, or extrahepatic.[1][2][3][4]

Staging

Intrahepatic cholangiocarcinoma staging

Stage T N M
IA T1 N0 M0
IB T2 N0 M0
IIA T3 N0 M0
IIB T1-3 N1 M0
III T4 Any N M0
IV Any T Any N M1
AJCC 2010
T Tis The tumour is only within the top layers of cells lining the bile duct
T1 There is one tumor that is contained within the bile duct, but has grown deeper into the wall of the bile duct
T2a There is one tumor and it has grown through the wall of the bile duct into a nearby blood vessel
T2b There is more than one tumour which may or may not have grown into a nearby blood vessel
T3  The tumour has either grown into the covering of the liver (the peritoneum) or has grown into nearby structures outside the liver, such as the bowel
T4 The tumour has spread into the liver by growing along the ducts
N N0 There are no cancer cells in the lymph nodes
N1 There are cancer cells in the lymph nodes
M M0 There is no sign of cancer spread
M1 The cancer has spread to other parts of the body away from the bile duct

Perhilar cholangiocarcinoma

Stage T N M
IA T1 N0 M0
IB T2 N0 M0
IIA T3 N0 M0
IIB T1-3 N1 M0
III T4 Any N M0
IV Any T Any N M1
AJCC 2010
T Tis The tumor is only within the top layers of cells lining the bile duct
T1 The tumor has grown deeper into the wall of the bile duct
T2a The tumor has grown through the wall of the bile duct into the fatty tissue around it
T2b The tumor has grown into the main part of the liver next to the bile duct
T3 The tumor has grown into one of the main blood vessels of the liver (the portal vein or hepatic artery)
T4 The tumour has grown into the right and left hepatic bile ducts. Or it has grown into more than one of the blood vessels. Or it has grown into a hepatic bile duct and more than one blood vessel
N N0 There are no cancer cells in the lymph nodes
N1 There are cancer cells in nearby lymph nodes
N2 There are cancer cells in lymph nodes further away, such as the chest
M M0 There is no sign of cancer spread
M1 The cancer has spread to other parts of the body far away from the bile duct

Extrahepatic cholangiocarcinoma

Stage T N M
IA T1 N0 M0
IB T2 N0 M0
IIA T3 N0 M0
IIB T1-3 N1 M0
III T4 Any N M0
IV Any T Any N M1
AJCC 2010
T Tis The tumor is only within the top layers of cells lining the bile duct
T1 The tumor is entirely inside the bile duct but has grown deeper into the bile duct wall
T2 The tumor has grown through the wall of the bile duct
T3 The tumor has grown into the gallbladder, pancreas, small bowel or other nearby organs
T4 The tumor has grown into the major blood vessel in the abdomen (the aorta) where it joins the main blood vessel of the liver (the hepatic artery)
N N0 There are no cancer cells in the lymph nodes
N1 There are cancer cells in the lymph nodes
M M0 There is no sign of cancer spread
M1 The cancer has spread to other parts of the body away from the bile duct

References

  1. Blechacz B, Komuta M, Roskams T, Gores GJ (2011). "Clinical diagnosis and staging of cholangiocarcinoma". Nat Rev Gastroenterol Hepatol. 8 (9): 512–22. doi:10.1038/nrgastro.2011.131. PMC 3331791. PMID 21808282.
  2. Patel T (2011). "Cholangiocarcinoma--controversies and challenges". Nat Rev Gastroenterol Hepatol. 8 (4): 189–200. doi:10.1038/nrgastro.2011.20. PMC 3888819. PMID 21460876.
  3. Groot Koerkamp B, Wiggers JK, Allen PJ, Busch OR, D'Angelica MI, DeMatteo RP, Fong Y, Gonen M, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR (2014). "American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions". HPB (Oxford). 16 (12): 1074–82. doi:10.1111/hpb.12320. PMC 4253330. PMID 25267346.
  4. Ronnekleiv-Kelly SM, Pawlik TM (2017). "Staging of intrahepatic cholangiocarcinoma". Hepatobiliary Surg Nutr. 6 (1): 35–43. doi:10.21037/hbsn.2016.10.02. PMC 5332207. PMID 28261593.

Template:WH Template:WS